Found 695 matching trials
Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
NAHigh blood pressure (BP) or hypertension (HTN) affects over 100 million ind...
Location
Boston Healthcare for the Homeless (BHCHP)
Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir
PHASE2The HIV epidemic represents one of the greatest health challenges worldwide...
Location
Hospital Universitario Ramón y Cajal
Study to Assess an Interphase Cycle With Flotetuzumab.
PHASE2Patients who have measurable residual disease (MRDpos, defined as MRD \> 0....
Location
NL-Amsterdam-VUMC
A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors
PHASE1This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Location
GSK Investigational Site
A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma
PHASE4This Phase IV study is an a multi-centre, randomised open label, two way cr...
Location
GSK Investigational Site
AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis
PHASE1One of the possible options for the treatment of MS at present is a high-do...
Location
First Pavlov State Medical University of St. Petersburg
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients
PHASE3The purpose of this study is to compare a standard chemotherapy regimen of ...
Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimenInduction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimenInduction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimenInduction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimenInduction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimenConsolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimenMaintenance (intensive & non-intensive pathways) - lenalidomide maintenanceMaintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenanceHigh dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis
PHASE4This study will determine whether the negative effects of combined oral con...
Location
Women's Health and Exercise Laboratories, The Pennsylvania State University
Allo HSCT Using RIC for Hematological Diseases
PHASE2This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Location
Masonic Cancer Center at University of Minnesota
NSCLC Isotoxic Hypofractionated Chemoradiotherapy
NARadiotherapy plays an important role in non-small cell lung cancer (NSCLC),...
Location
The Second Hospital of Hebei Medical University